Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
TriSalus Life Sciences, Inc. - Common Stock
(NQ:
TLSI
)
3.630
-0.270 (-6.92%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about TriSalus Life Sciences, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
October 07, 2024
Via
Benzinga
TriSalus Life Sciences Announces Appointment of Riad Salem, M.D., to its Scientific Advisory Board
September 26, 2024
From
TriSalus Life Sciences
Via
Business Wire
TriSalus Announces Journal of Vascular and Interventional Radiology Publication of Data that Demonstrate Improved Therapeutic Delivery of Glass Microspheres to Solid Tumors With PEDD™ Method via the TriNav® Infusion System
September 23, 2024
From
TriSalus Life Sciences
Via
Business Wire
TLSI Stock Earnings: TriSalus Life Sciences Beats EPS, Beats Revenue for Q2 2024
↗
August 15, 2024
TLSI stock results show that TriSalus Life Sciences beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
TriSalus Reports Q2 2024 Financial Results and Business Update
August 15, 2024
From
TriSalus Life Sciences
Via
Business Wire
TriSalus Life Sciences to Host Second Quarter 2024 Financial Results Conference Call
August 01, 2024
From
TriSalus Life Sciences
Via
Business Wire
TriSalus Life Sciences Announces Completion of Exchange Offer and Consent Solicitation
July 01, 2024
From
TriSalus Life Sciences
Via
Business Wire
TriSalus Life Sciences Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to Warrants
June 26, 2024
From
TriSalus Life Sciences
Via
Business Wire
TriSalus Life Sciences Highlights Clinical Data from Phase 1b PERIO-02 Trial, Studying Delivery of Nelitolimod via Pressure-Enabled Drug Delivery in Patients with Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma at 2024 ASCO Annual Meeting
June 03, 2024
From
TriSalus Life Sciences
Via
Business Wire
Crude Oil Rises 1%; Verastem Shares Slide
↗
May 24, 2024
Via
Benzinga
Why NetEase Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
May 24, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
May 24, 2024
Via
Benzinga
Nasdaq Gains 1%; Intuit Shares Plunge
↗
May 24, 2024
Via
Benzinga
TriSalus Life Sciences Announces Commencement of Exchange Offer and Consent Solicitation Relating to Warrants
May 24, 2024
From
TriSalus Life Sciences
Via
Business Wire
TLSI Stock Earnings: TriSalus Life Sciences Beats EPS, Beats Revenue for Q1 2024
↗
May 15, 2024
TLSI stock results show that TriSalus Life Sciences beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
TriSalus Reports Q1 2024 Financial Results and Business Update
May 15, 2024
From
TriSalus Life Sciences
Via
Business Wire
TriSalus Life Sciences Appoints Liselotte Hyveled to its Board of Directors
May 07, 2024
From
TriSalus Life Sciences
Via
Business Wire
TriSalus Life Sciences to Host First Quarter 2024 Financial Results Conference Call
May 06, 2024
From
TriSalus Life Sciences
Via
Business Wire
TriSalus Life Sciences Secures up to $50 million of Debt Financing with OrbiMed to Support TriNav® Infusion System Growth Initiatives
April 30, 2024
From
TriSalus Life Sciences
Via
Business Wire
TLSI Stock Earnings: TriSalus Life Sciences Misses EPS, Beats Revenue for Q4 2023
↗
April 01, 2024
TLSI stock results show that TriSalus Life Sciences missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
TriSalus Reports Q4 and Full Year 2023 Financial Results and Business Update
April 01, 2024
From
TriSalus Life Sciences
Via
Business Wire
Earnings Scheduled For April 1, 2024
↗
April 01, 2024
Companies Reporting Before The Bell • Mach Natural Resources (NYSE:MNR) is projected to report quarterly earnings at $0.92 per share on revenue of $213.43 million.
Via
Benzinga
TriSalus Life Sciences Technology Featured in Two Presentations at the Society of Interventional Radiology Annual Scientific Meeting
March 26, 2024
From
TriSalus Life Sciences
Via
Business Wire
TriSalus Life Sciences Announces Oral Presentations at the Upcoming 2024 Society of Interventional Radiology (SIR) Annual Scientific Meeting
March 21, 2024
From
TriSalus Life Sciences
Via
Business Wire
TriSalus Life Sciences Receives Approval from the World Health Organization and the American Medical Association’s Adopted Name Council for “Nelitolimod” as the Nonproprietary Drug Name for SD-101
March 07, 2024
From
TriSalus Life Sciences
Via
Business Wire
TriSalus Life Sciences Announces Real-World Data Demonstrating the Ability of TriNav® to Successfully Treat Patients with Higher Disease Burden and to Improve Delivery of Therapeutics to Liver Tumors
February 29, 2024
From
TriSalus Life Sciences
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
December 14, 2023
Via
Benzinga
TriSalus Reports Third Quarter 2023 Financial Results and Provides Business Update
November 14, 2023
From
TriSalus Life Sciences Inc.
Via
Business Wire
TriSalus Life Sciences to Host Third Quarter 2023 Financial Results Conference Call
November 07, 2023
From
TriSalus Life Sciences Inc.
Via
Business Wire
Late-Breaking Phase 1 Liver Metastasis Data from TriSalus Presented at SITC 2023 Supports Development of Innovative Immuno-oncology Approach for Liver and Pancreas Indications
November 04, 2023
From
TriSalus Life Sciences Inc.
Via
Business Wire
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
